Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
KISS1R encodes the kisspeptin receptor, a G-protein-coupled receptor essential for hypothalamic gonadotropin-releasing hormone (GnRH) secretion and pubertal onset. Loss-of-function variants in KISS1R disrupt GnRH pulsatility leading to normosmic congenital hypogonadotropic hypogonadism (nCHH) (MONDO:0018555). Clinically, affected individuals present with delayed puberty, primary amenorrhea and low sex-steroid levels.
The association between biallelic KISS1R variants and nCHH is classified as Strong by ClinGen criteria. This is supported by at least 12 unrelated probands across six consanguineous kindreds showing autosomal recessive inheritance and multi-generational segregation (affected relatives = 6), with concordant functional impairment in vitro ([PMID:23349759]; [PMID:30124894]).
Inheritance is autosomal recessive with compound heterozygous or homozygous variants. Case series include:
Functional assays demonstrate profound loss of KISS1R signaling and absence from the plasma membrane for missense and nonsense alleles (e.g., p.Leu318Pro). Intracellular calcium flux and MAP kinase activation are abolished in vitro. Pulsatile GnRH administration restores LH surges and fertility in affected women, confirming a hypothalamic-centric mechanism. These data meet ClinGen Moderate functional evidence supporting a loss-of-function mechanism.
Collectively, genetic and experimental data establish a robust AR gene–disease relationship. KISS1R testing should be included in gene panels for idiopathic hypogonadotropic hypogonadism. Identification of biallelic KISS1R mutations informs diagnosis, enables genetic counseling and guides GnRH-based therapeutic strategies.
Key Take-home: Biallelic loss-of-function KISS1R variants cause autosomal recessive normosmic congenital hypogonadotropic hypogonadism, with in vitro and in vivo rescue confirming clinical utility of GnRH therapy.
Gene–Disease AssociationStrong12 unrelated probands across six consanguineous kindreds, autosomal recessive segregation and concordant functional data Genetic EvidenceStrongMultiple homozygous and compound heterozygous variants in unrelated families with segregation consistent with autosomal recessive inheritance Functional EvidenceModerateIn vitro assays show loss of receptor signaling and membrane localization; GnRH therapy rescues hormonal response in vivo |